Explore the words cloud of the TOLLerant project. It provides you a very rough idea of what is the project "TOLLerant" about.
The following table provides information about the project.
Coordinator |
UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA
Organization address contact info |
Coordinator Country | Italy [IT] |
Project website | http://www.tollerant.eu |
Total cost | 3˙122˙539 € |
EC max contribution | 3˙122˙539 € (100%) |
Programme |
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers) |
Code Call | H2020-MSCA-ITN-2014 |
Funding Scheme | MSCA-ITN-ETN |
Starting year | 2015 |
Duration (year-month-day) | from 2015-01-01 to 2018-12-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA | IT (MILANO) | coordinator | 516˙122.00 |
2 | UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II | IT (NAPOLI) | participant | 516˙122.00 |
3 | KEMIJSKI INSTITUT | SI (LJUBLJANA) | participant | 469˙995.00 |
4 | VIB | BE (ZWIJNAARDE - GENT) | participant | 250˙560.00 |
5 | UNIVERSITAET BIELEFELD | DE (BIELEFELD) | participant | 249˙216.00 |
6 | AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS | ES (MADRID) | participant | 247˙872.00 |
7 | ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS | ES (DERIO VIZCAYA) | participant | 247˙872.00 |
8 | ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE | ES (SAN SEBASTIAN) | participant | 247˙872.00 |
9 | DIOMUNE SL | ES (MADRID) | participant | 247˙872.00 |
10 | LOFARMA S.P.A. | IT (MILAN) | participant | 129˙030.00 |
Based on an international team derived from the COST action BM1003 (www.cost-bm1003.info, 2011-2014) and thus relying on consolidated group interactions and synergies and on a unique combination of chemistry, biology, biophysics, biochemistry and pharmacology expertise, the TOLLerant project aims to gain information on molecular aspects of TLR4 activation and signaling by using synthetic and natural compounds and nanoparticles that interact selectively with some components (mainly MD-2 and CD14) of the TRL4 recognition system. TLR4 is an emerging molecular target related to an impressively broad spectrum of modern day disorders still lacking specific pharmacological treatment. These include autoimmune disorders, chronic inflammations, allergies, asthma, infectious and CNS diseases and cancer. The short-term scientific objective is to develop novel, non-toxic, synthetic and natural TLR4 modulators (agonists or antagonists) and to assess their therapeutic potential on animal models of TLR4-related acute and chronic pathologies that still lack efficient pharmacological treatment. The long-term scientific objective is to develop a new generation of innovative, TLR4-based therapeutics, to be used as vaccine adjuvants, anti-sepsis agents, and anti-inflammatory agents to treat chronic inflammations (allergy, asthma). The training programme will provide Early Stage Researchers (ESR) with broad competences, experience and skills in the cutting-edge, inter-disciplinary research in the field of chemical biology related to the molecular mechanisms of innate immunity and inflammation. During the training, the young researchers will be supported by senior scientists to cultivate their scientific, entrepreneurial and inter-cultural mindset. The non-academic sector will be committed to provide ESRs with entrepreneurship and company management skills, in order to enhance their employability by the private sector or even to motivate them to create own start-up companies.
Agenda | Documents, reports | 2019-07-22 08:10:45 |
TOLLerant website | Websites, patent fillings, videos etc. | 2019-05-22 20:37:28 |
Annual agenda of outreach activities | Documents, reports | 2019-07-22 08:10:53 |
Progress, periodic, midterm and final reports | Documents, reports | 2019-07-22 08:10:46 |
Minutes of training events | Documents, reports | 2019-07-22 08:10:45 |
TOLLerant linkedIn group | Websites, patent fillings, videos etc. | 2019-05-22 20:37:28 |
Consortium quarterly newsletter | Documents, reports | 2019-07-22 08:10:51 |
Training reports | Documents, reports | 2019-07-22 08:10:48 |
Protocols for molecular modelling | Demonstrators, pilots, prototypes | 2019-05-22 20:37:28 |
Dissemination plan | Documents, reports | 2019-05-22 20:37:29 |
Take a look to the deliverables list in detail: detailed list of TOLLerant deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2017 |
Florent Cochet, Francesco Peri The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling published pages: 2318, ISSN: 1422-0067, DOI: 10.3390/ijms18112318 |
International Journal of Molecular Sciences 18/11 | 2019-06-05 |
2017 |
Flaviana Di Lorenzo, Angelo Palmigiano, Katarzyna A. Duda, Mateusz Pallach, Nicolas Busset, Luisa Sturiale, Eric Giraud, Domenico Garozzo, Antonio Molinaro, Alba Silipo Structure of the Lipopolysaccharide from the Bradyrhizobium sp. ORS285 rfaL Mutant Strain published pages: 541-553, ISSN: 2191-1363, DOI: 10.1002/open.201700074 |
ChemistryOpen 6/4 | 2019-06-05 |
2018 |
Clara Barrau, Flaviana Di Lorenzo, Rodolfo Menes, Rosa Lanzetta, Antonio Molinaro, Alba Silipo The Structure of the Lipid A from the Halophilic Bacterium Spiribacter salinus M19-40T published pages: 124, ISSN: 1660-3397, DOI: 10.3390/md16040124 |
Marine Drugs 16/4 | 2019-06-05 |
2017 |
Flaviana Di Lorenzo, Angelo Palmigiano, Ida Paciello, Mateusz Pallach, Domenico Garozzo, Maria-Lina Bernardini, Violetta La Cono, Michail M. Yakimov, Antonio Molinaro, Alba Silipo The Deep-Sea Polyextremophile Halobacteroides lacunaris TB21 Rough-Type LPS: Structure and Inhibitory Activity towards Toxic LPS published pages: 201, ISSN: 1660-3397, DOI: 10.3390/md15070201 |
Marine Drugs 15/12 | 2019-06-05 |
2018 |
Fabio A. Facchini, Lenny Zaffaroni, Alberto Minotti, Silvia Rapisarda, Valentina Calabrese, Matilde Forcella, Paola Fusi, Cristina Airoldi, Carlotta Ciaramelli, Jean-Marc Billod, Andra B. Schromm, Harald Braun, Charys Palmer, Rudi Beyaert, Fabio Lapenta, Roman Jerala, Grisha Pirianov, Sonsoles Martin-Santamaria, Francesco Peri Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists published pages: , ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.7b01803 |
Journal of Medicinal Chemistry | 2019-06-05 |
2018 |
Flaviana Di Lorenzo, Angelo Palmigiano, Sami Albitar-Nehme, Mateusz Pallach, Maxim Kokoulin, Nadezhda Komandrova, Lyudmila Romanenko, Maria Lina Bernardini, Domenico Garozzo, Antonio Molinaro, Alba Silipo Lipid A Structure and Immunoinhibitory Effect of the Marine Bacterium Cobetia pacifica KMM 3879 T published pages: 2707-2716, ISSN: 1434-193X, DOI: 10.1002/ejoc.201800279 |
European Journal of Organic Chemistry 2018/20-21 | 2019-06-05 |
2018 |
Fabio A. Facchini, Helena Coelho, Stefania E. Sestito, Sandra Delgado, Alberto Minotti, David Andreu, Jesús Jiménez-Barbero, Francesco Peri Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor 4 Antagonist Activity of a Synthetic Glycolipid published pages: 280-287, ISSN: 1860-7179, DOI: 10.1002/cmdc.201700694 |
ChemMedChem 13/3 | 2019-06-05 |
2018 |
Lenny Zaffaroni, Francesco Peri Recent advances on Toll-like receptor 4Â modulation: new therapeutic perspectives published pages: , ISSN: 1756-8919, DOI: 10.4155/fmc-2017-0172 |
Future Medicinal Chemistry | 2019-06-05 |
2019 |
Giordano Traini, Ane Ruiz-de-Angulo, Juan Bautista Blanco-Canosa, Kepa Zamacola Bascarán, Antonio Molinaro, Alba Silipo, David Escors, Juan C. Mareque-Rivas Cancer Immunotherapy of TLR4 Agonist-Antigen Constructs Enhanced with Pathogen-Mimicking Magnetite Nanoparticles and Checkpoint Blockade of PD-L1 published pages: 1803993, ISSN: 1613-6810, DOI: 10.1002/smll.201803993 |
Small 15/4 | 2019-06-03 |
2017 |
Matilde de las Rivas, Erandi Lira-Navarrete, Earnest James Paul Daniel, Ismael Compañón, Helena Coelho, Ana Diniz, Jesús Jiménez-Barbero, Jesús M. Peregrina, Henrik Clausen, Francisco Corzana, Filipa Marcelo, Gonzalo Jiménez-Osés, Thomas A. Gerken, Ramon Hurtado-Guerrero The interdomain flexible linker of the polypeptide GalNAc transferases dictates their long-range glycosylation preferences published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-017-02006-0 |
Nature Communications 8/1 | 2019-05-22 |
2019 |
Giordano Traini, Ane Ruiz-de-Angulo, Juan Bautista Blanco-Canosa, Kepa Zamacola Bascarán, Antonio Molinaro, Alba Silipo, David Escors, Juan C. Mareque-Rivas Cancer Immunotherapy of TLR4 Agonist-Antigen Constructs Enhanced with Pathogen-Mimicking Magnetite Nanoparticles and Checkpoint Blockade of PD-L1 published pages: 1803993, ISSN: 1613-6810, DOI: 10.1002/smll.201803993 |
Small 15/4 | 2019-05-22 |
2018 |
Luigi Lembo-Fazio, Jean-Marc Billod, Flaviana Di Lorenzo, Ida Paciello, Mateusz Pallach, Sara Vaz-Francisco, Aurora Holgado, Rudi Beyaert, Manuel Fresno, Atsushi Shimoyama, Rosa Lanzetta, Koichi Fukase, Djamel Gully, Eric Giraud, Sonsoles MartÃn-SantamarÃa, Maria-Lina Bernardini, Alba Silipo Bradyrhizobium Lipid A: Immunological Properties and Molecular Basis of Its Binding to the Myeloid Differentiation Protein-2/Toll-Like Receptor 4 Complex published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2018.01888 |
Frontiers in Immunology 9 | 2019-05-22 |
2018 |
Fabio Lapenta, Jana AupiÄ, Žiga StrmÅ¡ek, Roman Jerala Coiled coil protein origami: from modular design principles towards biotechnological applications published pages: 3530-3542, ISSN: 0306-0012, DOI: 10.1039/c7cs00822h |
Chemical Society Reviews 47/10 | 2019-05-22 |
2017 |
Ajasja LjubetiÄ, Fabio Lapenta, Helena GradiÅ¡ar, Igor Drobnak, Jana AupiÄ, Žiga StrmÅ¡ek, DuÅ¡ko LainÅ¡Äek, Iva Hafner-BratkoviÄ, Andreja Majerle, NuÅ¡a Krivec, Mojca BenÄina, Tomaž Pisanski, Tanja Ćirković VeliÄković, Adam Round, José MarÃa Carazo, Roberto Melero, Roman Jerala Design of coiled-coil protein-origami cages that self-assemble in vitro and in vivo published pages: , ISSN: 1087-0156, DOI: 10.1038/nbt.3994 |
Nature Biotechnology | 2019-05-22 |
2018 |
Mateusz Pallach, Flaviana Di Lorenzo, Fabio Alessandro Facchini, Djamel Gully, Eric Giraud, Francesco Peri, Katarzyna A. Duda, Antonio Molinaro, Alba Silipo Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108 published pages: 1027-1035, ISSN: 0141-8130, DOI: 10.1016/j.ijbiomac.2018.08.035 |
International Journal of Biological Macromolecules 119 | 2019-05-22 |
2019 |
Florent Cochet, Fabio A. Facchini, Lenny Zaffaroni, Jean-Marc Billod, Helena Coelho, Aurora Holgado, Harald Braun, Rudi Beyaert, Roman Jerala, Jesus Jimenez-Barbero, Sonsoles Martin-Santamaria, Francesco Peri Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-018-37421-w |
Scientific Reports 9/1 | 2019-05-22 |
2016 |
Beatriz Salvador, Alicia Arranz, Sara Francisco, Laura Córdoba, Carmen Punzón, Miguel Ãngel Llamas, Manuel Fresno Modulation of endothelial function by Toll like receptors published pages: 46-56, ISSN: 1043-6618, DOI: 10.1016/j.phrs.2016.03.038 |
Pharmacological Research 108 | 2019-06-05 |
2016 |
Jean-Marc Billod, Alessandra Lacetera, Joan Guzmán-Caldentey, Sonsoles MartÃn-SantamarÃa Computational Approaches to Toll-Like Receptor 4 Modulation published pages: 994, ISSN: 1420-3049, DOI: 10.3390/molecules21080994 |
Molecules 21/8 | 2019-06-05 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TOLLERANT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "TOLLERANT" are provided by the European Opendata Portal: CORDIS opendata.